Rajkumar SV. Treatment of multiple myeloma. Nat Rev Clin Oncol. 8(8):479–91. https://doi.org/10.1038/nrclinonc.2011.63

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nau KC, Lewis WD. Multiple Myeloma: Diagnosis and treatment. Am Fam Physician. 2008;78(7):853–9.

PubMed  Google Scholar 

Bray F et al. ‘Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries’, CA. Cancer J. Clin., vol. n/a, no. n/a, https://doi.org/10.3322/caac.21834

Rajkumar SV, Merlini G, San Miguel JF. Redefining myeloma. Nat Rev Clin Oncol. 9(9):494–6. https://doi.org/10.1038/nrclinonc.2012.128.

Article  PubMed  Google Scholar 

Landgren O, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: A prospective study. Blood. 2009;113(22):5412–7. https://doi.org/10.1182/blood-2008-12-194241.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rajan AM, Rajkumar SV. Interpretation of cytogenetic results in multiple myeloma for clinical practice. Blood Cancer J. 5(10):e365. https://doi.org/10.1038/bcj.2015.92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Misund K, et al. MYC dysregulation in the progression of multiple myeloma. Leukemia. 2020;34(1):322–6. https://doi.org/10.1038/s41375-019-0543-4.

Article  PubMed  Google Scholar 

Walker BA, et al. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma’. Blood. 2018;132(6):587–97. https://doi.org/10.1182/blood-2018-03-840132.

Article  CAS  PubMed  PubMed Central  Google Scholar 

John L, Krauth MT, Podar K, Raab M-S. ‘Pathway-directed therapy in multiple myeloma. Cancers. 2021;13(7):1668. https://doi.org/10.3390/cancers13071668.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanamura I. Multiple myeloma with high-risk cytogenetics and its treatment approach. Int J Hematol. 2022;115(6):762–77. https://doi.org/10.1007/s12185-022-03353-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev. 2005;15(5):490–5. https://doi.org/10.1016/j.gde.2005.08.002.

Article  CAS  PubMed  Google Scholar 

Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Genes Dev. 2009;23(7):781–3. https://doi.org/10.1101/gad.1787609.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis. 2010;31(1):27–36. https://doi.org/10.1093/carcin/bgp220.

Article  CAS  PubMed  Google Scholar 

Sive JI, Feber A, Smith D, Quinn J, Beck S, Yong K. Global hypomethylation in myeloma is associated with poor prognosis. Br J Haematol. 2016;172(3):473–5. https://doi.org/10.1111/bjh.13506.

Article  PubMed  Google Scholar 

Galm O, et al. DNA methylation changes in multiple myeloma. Leukemia. 2004;18(10):1687–92. https://doi.org/10.1038/sj.leu.2403434.

Article  CAS  PubMed  Google Scholar 

Chim C-S, Liang R, Leung M-H, Yip S-F, Kwong Y-L. Aberrant gene promoter methylation marking disease progression in multiple myeloma. Leukemia. 2006;20(6):1190–2. https://doi.org/10.1038/sj.leu.2404205.

Article  CAS  PubMed  Google Scholar 

Salhia B, Baker A, Ahmann G, Auclair D, Fonseca R, Carpten J. DNA methylation analysis determines the high frequency of genic hypomethylation and low frequency of hypermethylation events in plasma cell tumors. Cancer Res. 2010;70(17):6934–44. https://doi.org/10.1158/0008-5472.CAN-10-0282.

Article  CAS  PubMed  Google Scholar 

Caprio C, Sacco A, Giustini V, Roccaro AM. Epigenetic aberrations in multiple myeloma. Cancers. 2020;12(10):2996. https://doi.org/10.3390/cancers12102996.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou Y, et al. High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2. Proc Natl Acad Sci U S A. 2010;107(17):7904–9. https://doi.org/10.1073/pnas.0908441107.

Article  PubMed  PubMed Central  Google Scholar 

Chi J, et al. MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival. Biol Direct. 6:23. https://doi.org/10.1186/1745-6150-6-23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wong K-Y, Liang R, So C-C, Jin D-Y, Costello JF, Chim C-S. Epigenetic silencing of MIR203 in multiple myeloma. Br J Haematol. 2011;154(5):569–78. https://doi.org/10.1111/j.1365-2141.2011.08782.x.

Article  CAS  PubMed  Google Scholar 

Bayraktar E, Bayraktar R, Oztatlici H, Lopez-Berestein G, Amero P, Rodriguez-Aguayo C. Targeting mirnas and other non-coding rnas as a therapeutic approach: An update. Non-Coding RNA. 2023;9(2):27. https://doi.org/10.3390/ncrna9020027.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samur MK, et al. Long intergenic non-coding rnas have an independent impact on survival in multiple myeloma. Leukemia. 2018;32(12):2626–35. https://doi.org/10.1038/s41375-018-0116-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ponjavic J, Ponting CP, Lunter G. Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res. 17(5):556–65. https://doi.org/10.1101/gr.6036807.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu Q, et al. Systematic comparison of lncRNAs with protein coding mRNAs in population expression and their response to environmental change. BMC Plant Biol. 17(1):42. https://doi.org/10.1186/s12870-017-0984-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou ZX, Chen XM, Zhang YQ, Peng L, Xue XY, Li GX. Comprehensive analysis of long noncoding RNA and mRNA in five colorectal cancer tissues and five normal tissues. Bio Rep. 2020;40(2):BSR20191139. https://doi.org/10.1042/BSR20191139

Wang C, et al. LncRNA structural characteristics in epigenetic regulation. Int J Mol Sci. 18(12):2659. https://doi.org/10.3390/ijms18122659.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morlando M, Fatica A. Alteration of epigenetic regulation by long noncoding rnas in cancer. Int J Mol Sci. 2018;19(2):570. https://doi.org/10.3390/ijms19020570.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aprile M, Katopodi V, Leucci E, Costa V. LncRNAs in cancer: From garbage to junk. Cancers. 2020;12(11):3220. https://doi.org/10.3390/cancers12113220.

Article  CAS  PubMed  PubMed Central  Google Scholar